215 related articles for article (PubMed ID: 10986181)
1. Participation in maternal serum screening for Down syndrome, neural tube defects, and trisomy 18 following screen-positive results in a previous pregnancy.
Rausch DN; Lambert-Messerlian GM; Canick JA
West J Med; 2000 Sep; 173(3):180-3. PubMed ID: 10986181
[TBL] [Abstract][Full Text] [Related]
2. Participation in maternal serum screening following screen positive results in a previous pregnancy.
Rausch DN; Lambert-Messerlian GM; Canick JA
J Med Screen; 2000; 7(1):4-6. PubMed ID: 10807139
[TBL] [Abstract][Full Text] [Related]
3. Maternal serum screening in Ontario using the triple marker test.
Summers AM; Farrell SA; Huang T; Meier C; Wyatt PR
J Med Screen; 2003; 10(3):107-11. PubMed ID: 14561260
[TBL] [Abstract][Full Text] [Related]
4. Prenatal screening for fetal aneuploidy in singleton pregnancies.
Chitayat D; Langlois S; Douglas Wilson R; ;
J Obstet Gynaecol Can; 2011 Jul; 33(7):736-750. PubMed ID: 21749752
[TBL] [Abstract][Full Text] [Related]
5. What can we do to prepare patients for test results during pregnancy?
Delzell JE
West J Med; 2000 Sep; 173(3):183-4. PubMed ID: 10986182
[No Abstract] [Full Text] [Related]
6. Triploidy identified through second-trimester serum screening.
Huang T; Alberman E; Wald N; Summers AM
Prenat Diagn; 2005 Mar; 25(3):229-33. PubMed ID: 15791661
[TBL] [Abstract][Full Text] [Related]
7. Maternal serum screening for Down's syndrome, open neural tube defects and trisomy 18.
Akbas SH; Ozben T; Alper O; Ugur A; Yücel G; Lüleci G
Clin Chem Lab Med; 2001 Jun; 39(6):487-90. PubMed ID: 11506458
[TBL] [Abstract][Full Text] [Related]
8. Maternal serum screening of Palestinian women in the West Bank.
Husseini A; Akkawi M
East Mediterr Health J; 2005 Jul; 11(4):824-7. PubMed ID: 16700399
[TBL] [Abstract][Full Text] [Related]
9. Triple marker screening for trisomy 21, trisomy 18 and open neural tube defects in singleton pregnancies of native Japanese pregnant women.
Onda T; Tanaka T; Yoshida K; Nakamura Y; Kudo R; Yamamoto H; Sato A; Yanagida K; Takai Y; Uemura H; Hoshi K; Fukada Y; Miyake Y; Ohnishi M; Kaneoka T; Makino Y; Murata Y; Kanzaki T; Kanzaki H; Osaki T; Aono T; Maeda K; Ogita S; Yamamasu S; Aso T; Shimizu Y; Izutsu T; Kudo T; Okai T; Sakai M; Hashimoto T; Matsuzaki N; Kitagawa M; Sago H; Grier RE; Myrick F; Shimizu Y
J Obstet Gynaecol Res; 2000 Dec; 26(6):441-7. PubMed ID: 11152330
[TBL] [Abstract][Full Text] [Related]
10. Prenatal screening using maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated estriol: two-year experience in a health maintenance organization.
McDuffie RS; Haverkamp AD; Stark CF; Haverkamp C; Barth CK
J Matern Fetal Med; 1996; 5(2):70-3. PubMed ID: 8796771
[TBL] [Abstract][Full Text] [Related]
11. The implications of a false positive second-trimester serum screen for Down syndrome.
Summers AM; Huang T; Meier C; Wyatt PR
Obstet Gynecol; 2003 Jun; 101(6):1301-6. PubMed ID: 12798540
[TBL] [Abstract][Full Text] [Related]
12. Obstetrical complications associated with abnormal maternal serum markers analytes.
Gagnon A; Wilson RD;
J Obstet Gynaecol Can; 2008 Oct; 30(10):918-932. PubMed ID: 19038077
[TBL] [Abstract][Full Text] [Related]
13. Trisomy 18 fetuses with cystic hygroma linked to positive maternal serum Down's syndrome Triple test screening result.
Celentano C; Guanciali-Franchi PE; Liberati M; Prefumo F; Palka G; Rotmensch S
J Med Screen; 2005; 12(4):203. PubMed ID: 16417699
[No Abstract] [Full Text] [Related]
14. Down syndrome and neural tube defect screening: the value of using gestational age by ultrasonography.
Benn PA; Borgida A; Horne D; Briganti S; Collins R; Rodis JF
Am J Obstet Gynecol; 1997 May; 176(5):1056-61. PubMed ID: 9166168
[TBL] [Abstract][Full Text] [Related]
15. Estimates for the sensitivity and false-positive rates for second trimester serum screening for Down syndrome and trisomy 18 with adjustment for cross-identification and double-positive results.
Benn PA; Ying J; Beazoglou T; Egan JF
Prenat Diagn; 2001 Jan; 21(1):46-51. PubMed ID: 11180240
[TBL] [Abstract][Full Text] [Related]
16. Detection rate of quadruple-marker screening determined by clinical follow-up and registry data in the statewide California program, July 2007 to February 2009.
Kazerouni NN; Currier RJ; Flessel M; Goldman S; Hennigan C; Hodgkinson C; Lorey F; Malm L; Tempelis C; Roberson M
Prenat Diagn; 2011 Sep; 31(9):901-6. PubMed ID: 21706514
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of maternal serum screening in the prenatal detection of fetal chromosome abnormalities in Japanese women.
Kishida T; Hoshi N; Hattori R; Negishi H; Yamada H; Okuyama K; Hanatani K; Takagi T; Sagawa T; Fujimoto S
Fetal Diagn Ther; 2000; 15(2):112-7. PubMed ID: 10720877
[TBL] [Abstract][Full Text] [Related]
18. [Predictive value of abnormal second-trimester maternal serum triple screening markers for adverse pregnancy outcomes].
Hu Z; Liu X; Li L; Jia C; Li D; Liu R
Zhonghua Fu Chan Ke Za Zhi; 2014 Oct; 49(10):749-53. PubMed ID: 25537246
[TBL] [Abstract][Full Text] [Related]
19. 'Dual positivity' for neural tube defects and down syndrome at maternal serum screening: gestational outcome.
Zanini R; Tarantini M; Cerri V; Jacobello C; Bellotti D; Lancetti S; Scalchi S; Groli C; Bianchi UA
Fetal Diagn Ther; 1998; 13(2):106-10. PubMed ID: 9650657
[TBL] [Abstract][Full Text] [Related]
20. The identification of risk of spontaneous fetal loss through second-trimester maternal serum screening.
Huang T; Owolabi T; Summers AM; Meier C; Wyatt PR
Am J Obstet Gynecol; 2005 Aug; 193(2):395-403. PubMed ID: 16098861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]